About Aier

龍巖愛爾眼科醫院有限公司是中國大規模的眼科醫療連鎖機構,IPO上市醫療機構(股票代碼: 300015,2015年入選滬深300指數股)。截至2017年7月,已在全國30個省市區建立180余家專業眼科醫院,覆蓋全國醫保人口超過70%,年門診量超過400 萬人。并且,在香港、美國和歐洲也開設有眼科分支機構。

Aier Eye Hospital Group is China's leading hospital network in eye care, and is also China's first IPO listed medical institution (stock code: 300015, one of the CSI 300 index selected in 2015). As of July 2017, Aier Eye Hospital Group has established more than 180 specialized eye hospitals covering 30 provinces and extended our services to 70% of insured population all over the country with over 4 million outpatient visits annually. Recently, we have successfully established our presence in Hongkong,US and Europe.


Aier is committed to the parallel introduction and absorption of world-leading ophthalmic technology and management concept, with professionalism, scale and science as its strategy to advance the development of China's ophthalmic medical care.


Base on constant exploration and practice, also with absorb advanced international medical management experience, Aier Eye Hospital Group has successfully established the "hierarchical chain" management model that adapts to China's market environment. Utilizing our advantages in talent, technology and management, we aim to provide the most trusted eye care to patients all over the country.


In 2013, Aier and Central South University jointly set up Aier School of ophthalmology, CSU, to educate and train medical professionals with advanced degrees; Once again in 2014, Aier joined the Hubei University of Science and Technology to establish the Aier School of Ophthalmology & Optometry. In 2011 and 2015, Aier established the Aier Institute of Optometry and Aier Institute of Ophthalmology respectively. At this point, Aier has bridged all three areas of medicine, education and research, the establishment of these educational and research institutions will significantly boost our research and clinical standards.


As of 2016, Aier has recruited and trained over 3000 doctors and specialized experts, many of whom have studied in elite institutions in Europe and the US. They are China’s driving force in ophthalmology.


On July 9,2014, the President of the World Bank Jim Yong Kim visited Changsha Aier Eye Hospital and promoted Aier’s unique sustainable philanthropic model in developing countries. In 2015, Aier acquired Hong Kong Asia Medical Group and paved the way for Aier’s internationalization. In early 2017, Aier acquired a renowned eyecare center in American, which brought Aier’s international expansion to a new stage.


Since its founding, Aier always committed to the mission, “Everyone in everywhere, we do care?“. With its "cross subsidy" model, Aier provides patients with higher quality services, in the meantime dedicate itself to the social welfare and helping vulnerable groups to promote the cause of fighting blindness.

隨著中國醫療衛生體制改革的進一步推進,愛爾眼科順應國家醫療衛生政策和發展趨勢,于2014年在醫療行業推出“合伙人計劃”,致力于改變眼科醫生執業的生態環境,限度地激發核心骨干的力和能動性。愛爾眼科專注于眼科醫療服務事業,預計到 2017年,興建200家具有競爭力的專業連鎖眼科醫院,為更多的人提供高質量、多層次的眼科醫療服務。

In 2014, Aier launched the "Partnership Program" in the healthcare industry to focus on changing the ecological environment for ophthalmologists and maximizing the creativity and initiative of core members. It is expected that by the end of 2017, Aier will have 200 eye hospitals which provide high quality and multi-level eye care to more people.


有没有一款自动赚钱的软件 体彩幸运赛车开奖直播 麻将来了旧版本官网 一肖中特网页精选结果 喜乐彩玩法 广东南粤好彩1开奖结果 不用联网不用流量的捕鱼游戏 打麻将技巧十句口诀 七乐彩组号的独门技巧 赛车pk10开奖软件 快速赛车是真是假 十一选五乐三中奖规则 黑龙江福彩36选7历史开奖 能够赚钱的网络游戏 2020年最有潜力的股票 上海天天选四今天 炒股